<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Roswell Park Memorial Institute (RPMI) 1640 medium and fetal bovine serum (FBS) were purchased from GIBCO BRL (Grand Island, NY, USA). The oregano essential oil (OEO) was obtained from Meritech Bioengineering Co. Ltd. (Guangzhou, China), and its composition is shown in 
 <xref ref-type="app" rid="app1-molecules-23-01857" class="xref">Supplementary Table S1 and Figure S1</xref>. The processing method of the OEO included mixing seeds, seedling cultivation, planting, harvesting, distillation and refining, quality inspection, qualified essential oil screening, and storage. The OEO was completely soluble in dimethyl sulphoxide (DMSO). The LPSs (
 <italic class="italic">Escherichia coli</italic> O127: B8) were from Sigma (St. Louis, MO, USA). The 2′,7′-dichlorofluorescein-diacetate (DCFH2-DA), diphenyleneiodonium chloride (DPI), and 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2
 <italic class="italic">H</italic>-tetrazolium bromide (MTT) were from Sigma-Aldrich (St. Louis, MO, USA). The anti-phospho p38 MAPK, anti-phospho anti-c-Jun N-terminal protein kinase (JNK), and anti-β-actin were from Cell Signaling Technology (Beverly, MA, USA). The anti-p38 MAPK, JNK, and anti-extracellular signal-regulated kinases 1/2 (ERK1/2) were from Affinity Biosciences (Columbus, OH, USA). The anti-proliferating cell nuclear antigen (PCNA) was from BD Transduction Laboratories (San Diego, CA, USA). The RAW264.7 cells were obtained from the Chinese Academy of Sciences Institution (Chinese Academy of Sciences, Guangzhou, China). The OEO was dissolved in the serum-containing medium to achieve the final desired concentration.
</p>
